NCT05338931
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Asan Medical Center Seoul, South Korea
Clinical trial condition
B-cell Non Hodgkin Lymphoma
Explore clinical trials studying B-cell Non Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.
29 public trials
11 recruiting studies
B-cell Non Hodgkin Lymphoma trial results
Not Yet Recruiting
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
NCT07225439
- Conditions
- B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
- Locations
-
- Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
Not Yet Recruiting
Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies
NCT07335328
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Not Yet Recruiting
Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
NCT05779930
- Conditions
- Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia, in Relapse, B Cell Leukemia, +22 more
- Locations
-
- Nationwide Children's Hospital Columbus, Ohio, United States
Not Yet Recruiting
ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT
NCT06646666
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Department of Hematology, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China
NCT05927558
- Conditions
- B-cell Non Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Ematologia Istituto Nazionale Tumori Milan, Italy
NCT04088890
- Conditions
- B-ALL, B-cell Non Hodgkin Lymphoma, DLBCL, +11 more
- Locations
-
- Stanford Medical Center Stanford, California, United States
NCT01516580
- Conditions
- B-cell Non Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +16 more
- Locations
-
- University Hospitals Leuven Leuven, Belgium
- Children Oncology Group Operations centres Monrovia, Canada
- The University of Hong Kong (Clinical Trials Centre) Hong Kong, China
- Institut de Cancérologie Gustave roussy Villejuif, France
NCT06027957
- Conditions
- B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma, Burkitt Lymphoma, +16 more
- Locations
-
- Vinmec Research Institute of Stem Cell and Gene Technology Hanoi, Vietnam
NCT03870945
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Klinikum Augsburg, II. Med. Klinik Haematologie / Onkologie Augsburg, Bavaria, Germany
- University Hospital Cologne - Department for Internal Medicine I Cologne, North Rhine-Westphalia, Germany
- Universitätsklinikum Hamburg-Eppendorf, Department of Stem Cell Transplantation Hamburg, Germany